1. Aarkstore.com announces, The Latest market research report is
available in its vast collection:
Pre-Eclampsia – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Pre-Eclampsia - Pipeline Review, H1 2012,
provides an overview of the Pre-Eclampsia therapeutic pipeline. This
report provides information on the therapeutic development for Pre-
Eclampsia , complete with latest updates, and special features on late-
stage and discontinued projects. It also reviews key players involved in the
therapeutic development for Pre-Eclampsia . Pre-Eclampsia - Pipeline
Review, H1 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC
filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.
Scope
2. - A snapshot of the global therapeutic scenario for Pre-Eclampsia .
- A review of the Pre-Eclampsia products under development by companies
and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging
from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Pre-Eclampsia Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Pre-Eclampsia 6
Pre-Eclampsia Therapeutics under Investigation by Universities/Institutes
8
Late Stage Products 9
Comparative Analysis 9
Pre-Eclampsia Therapeutics – Products under Investigation by
Universities/Institutes 10
Pre-Eclampsia – Therapeutics Assessment 11
Assessment by Monotherapy Products 11
Assessment by Combination Products 12
Assessment by Route of Administration 13
Assessment by Molecule Type 15
Drug Profiles 17
Lovenox + Aspegic - Drug Profile 17
Product Description 17
Mechanism of Action 17
3. R&D Progress 17
Atorvastatin - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Benazepril - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Pre-Eclampsia Therapeutics – Discontinued Products 21
Pre-Eclampsia Therapeutics - Dormant Products 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
4. Sezary Syndrome – Pipeline Review, H1 2012
Pre-Eclampsia – Pipeline Review, H1 2012
Herpes Labialis (Oral Herpes) – Pipeline Review, H1 2012
Raynauds Disease – Pipeline Review, H1 2012
Fragile X Syndrome – Pipeline Review, H1 2012
Bronchiolitis Obliterans – Pipeline Review, H1 2012
Cancer Cachexia – Pipeline Review, H1 2012
Hyperuricemia – Pipeline Review, H1 2012
Sarcoidosis – Pipeline Review, H1 2012
Optic Nerve Injury – Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise